Abstract

Evaluation of Ultrasensitive C-Reactive Protein as a Cardiovascular Risk Marker in Pediatric Patients with End-Stage Renal Disease on Peritoneal Dialysis

Highlights

  • Patients with End-Stage Renal Disease (ESRD) are at elevated risk for morbidity and mortality due to cardiovascular disease [1,2]

  • Ultrasensitive C-Reactive Protein (USCRP) could be superior to other Risk Factors (RF) in detecting the damage

  • As compared to the general population, adverse cardiac events occur at rates 30 times higher in patients with End-Stage Renal Disease (ESRD) and 700 times higher in patients on renal replacement therapy (Peritoneal Dialysis (PD) or hemodialysis), with a concomitant 10-year decrease in life expectancy 10 years after diagnosis [3,4,5,6]

Read more

Summary

Introduction

Patients with End-Stage Renal Disease (ESRD) are at elevated risk for morbidity and mortality due to cardiovascular disease [1,2]. The main cardiovascular complications found in pediatric ESRD patients include left ventricular abnormalities (initially hypertrophic and dilated cardiomyopathy); arrhythmias; pericardial complications (pericarditis and tamponade); and abnormalities indicative of early atherosclerosis, such as thickening of the carotid intimae, and endothelial dysfunction, as measured by brachial artery flow [7,8,9,10]. Patients with End-Stage Renal Disease (ESRD) on Peritoneal Dialysis (PD) experience high morbidity and mortality due to Cardiovascular (CV) disease. The objective was to assess CV risk in pediatric patients with ESRD on PD and evaluate the utility of USCRP as a CV risk marker

Objectives
Methods
Results
Conclusion

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call

Disclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.